Barry H. Wells, M.D.

Barry H. Wells, M.D., has devoted his career to eliminating disease. After nearly four decades as a urologist and surgeon treating patients suffering from kidney stones, urinary tract infections and other urological issues, he broadened his scope to help American Gene Technologies® in its mission to use the power of gene therapy to relieve human suffering from serious diseases.

Dr. Wells had already been part of the company’s investor relations team for three years when he was elevated to Head of Business Development. He has consistently been a strong believer in the company’s potential to bring desperately needed cures to suffering patients.

In addition to medicine, Dr. Wells has also long been interested in business and technology. He formed two small-business ventures and has raised funds for New Sapience, an AI company in its early stage of growth.

Dr. Wells earned his bachelor of arts degree in 1977 at the University of Kansas, where his academic achievement led to his election to Phi Beta Kappa. He graduated from the Kansas University School of Medicine with his M.D. in 1983. He completed a residency in urologic surgery at the University of Maryland Medical Center from 1983 to 1988.